You are here

Article Text

Article menu
Download PDFPDF
Letters
Gonorrhoea surveillance in Ghana, Africa
  1. C Duplessis1,
  2. N Puplampu2,
  3. E Nyarko3,
  4. J Carroll3,
  5. Dela Helena2,
  6. A Mensah3,
  7. A Amponsah3,
  8. JL Sanchez4
  1. 1 Naval Medical Research Center (NMRC), Biological Defense Research Directorate (BDRD), Silver Spring, Maryland USA
  2. 2 U.S. Naval Medical Research Unit No. 3 and Global Disease Detection Regional Center, (GDDRC), U.S. Centers for Disease Control and Prevention Adjacent to Abbassia Fever Hospital, Cairo, Egypt
  3. 3 Ghana Armed Forces, Ghana Africa
  4. 4 Armed Forces Health Surveillance Center (AFHSC) and Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF), Silver Spring, Maryland, USA
  1. Correspondence to Dr Christopher Duplessis, Naval Medical Research Center (NMRC), 814 Blakely Court Frederick Md 20712, Silver Spring, MD 20712, USA; chris.duplessis{at}waldenu.edu.

http://dx.doi.org/10.1136/sextrans-2013-051296

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Multidrug-resistant Neisseria gonorrhoeae necessitates surveillance. We implemented gonorrhoea surveillance in Ghana to characterise prevalence and resistance, hitherto undefined. Despite a paucity of data, gonorrhoea resistance may be predicted given contemporary indiscriminate antimicrobial usage, and stewardship, suspect antimicrobial compliance, increasing global travel and lack of laboratory infrastructure.

    Gonorrhoea surveillance was executed from June 2012 to March 2013. The population encompassed a convenience sampling of patients presenting with sexually transmitted illness (STI) symptoms to participating clinics in Accra and Takoradi, Ghana. Participants provided a urine sample for NAAT testing for chlamydia and gonorrhoea. The LightMix kits to detect N gonorrhoeae (TIB MOLBIOL, Berlin, Germany) and Chlamydia trachomatis …

    View Full Text

    Footnotes

    • Contributors CD and NP contributed to planning and execution of the study and manuscript writing. EN and JC were the site coordinators executing study onsite at clinics and contributed to the manuscript. DH, AM, and AA executed the lab processing of samples. JLS was the director of the funding body and contributed to the manuscript and planning of this study.

    • Funding AFHSC.

    • Disclaimer The opinions stated are those of the authors and do not represent the official position of the US Department of Defense, local country Ministries of Health, Agriculture, or Defense, or other contributing network partner organisations. Mention of any commercial product does not imply DoD endorsement or recommendation for or against the use of any such product. No infringement on the rights of the holders of the registered trademarks is intended.

    • Competing interests None.

    • Patient consent Obtained.

    • Ethics approval NAMRU-3, NMIMR.

    • Provenance and peer review Not commissioned; internally peer reviewed.